|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145) : a pooled analysis of more than 1,300 patients in 4 phase II trials显示文摘 | Raal FJ Giugliano RP Sabatine MS | 2014 | J Am Coil Cardiol2014，63，13： | 1 |
| 2 | Leptin, adiponeetin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blackswith and without coro- nary artery disease显示文摘 | Ntyintyane L Panz V Raal FJ | 2009 | Metab Syndr Relat Disord2009，7，3： | 1 |
| 3 | A dose-titration andcomparative study of rosuvastatin and atorvastatin in patientswith homozygous familial hypercholesterolaemia显示文摘 | Marais AD Raal FJ Stein EA | 2008 | Athero-sclerosis2008，，： | 1 |
| 4 | Performance of the Cardio- Chek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids 显示文摘 | Panz VR Raal FJ Paiker J | 2005 | Cardiovasc J S Afr2005，16，2： | 1 |
| 5 | Leptin, adiponectin, and high- sensitivity C-reactive protein in relation to the metabolic syndrome in urban South Mrican blacks with and without coronary artery disease 显示文摘 | Ntyintyane L Panz V Raal FJ | 2009 | Metab Syndr Relat Disord2009，7，3： | 1 |
| 6 | PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia :results of a randomised, double-blind, placebo-controlled trial 显示文摘 | Raal FJ Stein EA Dufour R | 2015 | Lancet2015，385，1： | 1 |
| 7 | Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial显示文摘 | KOREN MJ GIUGLIANO R P RAAL FJ | 2014 | Circulation2014，129，2： | 1 |
| 8 | Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1显示文摘 | Panz VR Bonegio R Raal FJ | | 0，，04： | 1 |
| 9 | Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia显示文摘 | Raal FJ Panz VR Pilcher GJ | 1999 | Intern Med1999，246，1： | 1 |
| 10 | The evaluation of low-density lipoprotein cholesterol goals achieved on patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy:the South African Not At Goal study( SANAG) 显示文摘 | Ramjeeth A Butkow N Raal FJ | 2008 | Cardiovasc J Afr2008，19，2： | 1 |
| 11 | Targeting LDL: is lower better and is it safe?显示文摘 | Stein EA Raal FJ | 2014 | Best Pract Res Clin Endocrinol Metab2014，28，3： | 1 |
| 12 | PCSK9 inhibitionwith evolocumab (AMG 145) in heterozygous familialhypercholesterolaemia (RUTHERFORD-2): a randomised,double-blind, placebo-controlled trial 显示文摘 | Raal FJ Stein EA Dufour R | 2015 | Lancet2015，385，9965： | 1 |
| 13 | Leptin,adiponectin,and highsensitivity C-reactive protein in relation to the metabolic syndrome in urban south African blacks with and without coronary artery disease显示文摘 | Ntyintyane L Panz V Raal FJ | | 0，，03： | 1 |
| 14 | Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia(TESLA Part B):a randomised,double-blind,placebocontrolled trial显示文摘 | RAAL FJ HONARPOUR N BLOM DJ | 2015 | Lancet2015，385，9965： | 1 |
| 15 | Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B) : a randomised, double-blind, placebo-controlled trial显示文摘 | Raal FJ Honarpour N Biota DJ | 2015 | Lancet2015，385，9965： | 1 |
| 16 | PCSK9 inhibition with evolocumab(AMG 145)in heterozygous familial hypercholesterolaemia(RUTHERFORD-2):a randomised,double-blind,placebo-controlled trial显示文摘 | RAAL FJ STEIN EA DUFOUR R | 2015 | Lancet2015，385，9965： | 1 |
| 17 | Efficacy and safety of longer-term administration of evolocumab(AMG 145)in patients with hypercholesterolemia:2-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C(OSLER)randomized trial显示文摘 | KOREN MJ GIUGLIANO RP RAAL FJ | 2014 | Circulation2014，129，2： | 1 |
| 18 | Autosomal recessive hypercholesterolaemia: discrimination of ARH protein and LDLR function in the homozygous FH phenotype 显示文摘 | Abera AB Marais AD Raal FJ | 2007 | Clin Chim Acta2007，378，12： | 1 |
| 19 | Insulin receptor substrate-1 gene variants in lipoatrephic diabetes mellitus and NIDDM :astudy of South African black and white subjects显示文摘 | Panz VR Raal FJ RahiUy SO | 1997 | Hum Genet1997，19，1： | 1 |
| 20 | Reduction in mortality in subjects with homozygous familial hypercholest- erolemis associated with advances in lipid- lowering therapy显示文摘 | RAAL FJ PILCHER GJ PANZ VR et a1 | 2011 | Circulation2011，124，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员